DocuGuru
SAGE

Therapeutic Advances in Respiratory Disease Template

Write in a clean editor, then format for Therapeutic Advances in Respiratory Disease in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

Use this template

About the Therapeutic Advances in Respiratory Disease format

Therapeutic Advances in Respiratory Disease is a peer-reviewed journal published by SAGE, covering Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, Respiratory Support and Mechanisms.

PublisherSAGE
Reference styleAuthor–year (Harvard)
Author–year — (Smith, 2023) in the text
Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Therapeutic Advances in Respiratory Disease, 12(3), pp. 45–58.

Formats any DOI in Therapeutic Advances in Respiratory Disease style. No sign-up.

Publishes research inChronic Obstructive Pulmonary Disease (COPD) Research Asthma and respiratory diseases Respiratory Support and Mechanisms Respiratory and Cough-Related Research Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
ISSN1753-4658
Citation impact (2-yr)3.31
h-index67
i10-index532
Total citations21,671
Article processing charge$2,300
Open accessYes
Top institutions publishing hereFirst Affiliated Hospital of Guangzhou Medical University
Journal websiteus.sagepub.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Therapeutic Advances in Respiratory Disease per year

19
2014
42
2015
51
2016
26
2017
39
2018
61
2019
95
2020
49
2021
67
2022
79
2023
95
2024
105
2025

Citation impact of Therapeutic Advances in Respiratory Disease by publication year

395
2014
1.5K
2015
1.6K
2016
859
2017
1.9K
2018
1.7K
2019
2.6K
2020
1K
2021
1.2K
2022
763
2023
461
2024
312
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Therapeutic Advances in Respiratory Disease

Defining the relationship between COPD and CVD: what are the implications for clinical practice?

Ann Morgan, Rosita Zakeri, Jennifer K Quint · 1 Jan 2018

Cardiovascular diseases (CVDs) are arguably the most important comorbidities in chronic obstructive pulmonary disease (COPD). CVDs are common in people with COPD, and their presence is associated with increased risk for hospitalization, longer length of stay and all-cause and CVD-related mortality. The economic burden associated with CVD in this population is considerable and the cumulative…

336 citations Cite SaveGo to paper →
The pathogenesis of idiopathic pulmonary fibrosis

William R. Coward, Gauri Saini, Gísli Jenkins · 15 Oct 2010

Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with an appalling prognosis. The failure of anti-inflammatory therapies coupled with the observation that deranged epithelium overlies proliferative myofibroblasts to form the fibroblastic focus has lead to the emerging concept that IPF is a disease of deregulated epithelial-mesenchymal crosstalk. IPF is triggered by an as…

276 citations Cite SaveGo to paper →
The airway epithelium: more than just a structural barrier

Anthony Raymond Tam, Samuel Wadsworth, Delbert R. Dorscheid et al. · 3 Mar 2011

The mammalian airway is lined by a variety of specialized epithelial cells that not only serve as a physical barrier but also respond to environment-induced damage through the release of biologically active factors and constant cellular renewal. The lung epithelium responds to environmental insults such as pathogens, cigarette smoke and pollution by secreting inflammatory mediators…

240 citations Cite SaveGo to paper →
The burden of allergic rhinitis and asthma

Tunis Özdoğanoğlu, Murat Songu · 16 Dec 2011

Asthma and allergic rhinitis are common health problems that cause major illness and disability worldwide. The prevalence of allergic rhinitis is estimated to range from 10% to 20% in the USA and Europe. Multiple factors contribute to the wide range of reported prevalence rates. These include type of prevalence rate reported (current or cumulative), study…

202 citations Cite SaveGo to paper →
Prevalence of α1-antitrypsin deficiency alleles PI*S and PI*Z worldwide and effective screening for each of the five phenotypic classes PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ: a comprehensive review

Frederick J. de Serres, Ignacio Blanco · 29 Aug 2012

Genetic epidemiological studies on the prevalence and numbers of individuals with α1-antitrypsin deficiency in each of 97 countries worldwide were used to estimate the numbers in each of the five following phenotypic classes: PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ. These 97 countries were then grouped into 10 major geographic regions to make it possible to…

195 citations Cite SaveGo to paper →

Therapeutic Advances in Respiratory Disease template — frequently asked questions

How do I write a paper in the Therapeutic Advances in Respiratory Disease format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Therapeutic Advances in Respiratory Disease template. When you export, DocuGuru compiles the paper into the official SAGE format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Therapeutic Advances in Respiratory Disease use?
Therapeutic Advances in Respiratory Disease uses Author–year (Harvard) references, shown as author–year markers such as (Smith, 2023) in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Therapeutic Advances in Respiratory Disease, 12(3), pp. 45–58.
Do I need to know LaTeX to submit to Therapeutic Advances in Respiratory Disease?
No. DocuGuru generates the sagej LaTeX class and compiles the PDF for you in the background, so you get a SAGE-ready Therapeutic Advances in Respiratory Disease document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Therapeutic Advances in Respiratory Disease template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Therapeutic Advances in Respiratory Disease format with correct headings, figures, tables, and author–year citations.
Who publishes Therapeutic Advances in Respiratory Disease?
Therapeutic Advances in Respiratory Disease is a multidisciplinary journal published by SAGE. DocuGuru's Therapeutic Advances in Respiratory Disease template matches SAGE's official submission format.
Can I export a submission-ready Therapeutic Advances in Respiratory Disease PDF?
Yes — DocuGuru produces a PDF built with the official Therapeutic Advances in Respiratory Disease template (the sagej class) that is ready to submit to SAGE, together with the matching LaTeX source files.
How much does the Therapeutic Advances in Respiratory Disease template cost?
You can start writing in the Therapeutic Advances in Respiratory Disease template for free. Exporting the final submission-ready Therapeutic Advances in Respiratory Disease PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Therapeutic Advances in Respiratory Disease template